Business Context and Reporting Period
This Form 8-K Current Report was filed by iBio, Inc. on February 21, 2024, covering events occurring on February 15, 2024. The filing addresses a change in the Company's independent registered public accounting firm for the fiscal year ending June 30, 2024.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on the transition of the external audit firm.
Material Changes
- Engagement of New Auditor: The Audit Committee approved the engagement of Grassi & Co., CPAs, P.C. ("Grassi") as the independent registered public accounting firm effective February 20, 2024, for the fiscal year ending June 30, 2024.
- Resignation of Previous Auditor: CohnReznick LLP ("CohnReznick") resigned as the independent registered public accounting firm effective February 15, 2024. The resignation was not initiated or approved by the Audit Committee.
- Audit Opinion History: CohnReznick's reports for fiscal years ended June 30, 2023, and 2022, did not contain adverse or qualified opinions. However, the 2023 report included an explanatory paragraph regarding the Company's ability to continue as a "going concern."
- Disagreements and Reportable Events: There were no disagreements between the Company and CohnReznick regarding accounting principles or auditing scope. A material weakness in internal controls related to stock-based compensation was identified in the quarter ended March 31, 2023, but was fully remediated by June 30, 2023.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The primary risk highlighted is the historical "going concern" qualification noted in the prior fiscal year's audit report, though no new risks were disclosed in this specific filing.
Investor Verification Checklist
- Verify the status of the "going concern" qualification noted in the June 30, 2023, audit report to assess current liquidity risks.
- Review the engagement letter with Grassi & Co. to confirm the scope of the upcoming audit.
- Confirm that the material weakness in stock-based compensation controls remains remediated as of the current period.
- Monitor for any future filings explaining the specific reasons for CohnReznick's unsolicited resignation.